share_log

Virios Therapeutics | 4: Statement of changes in beneficial ownership of securities-CHIEF EXECUTIVE OFFICER Duncan Gregory Scott

SEC ·  Aug 18, 2023 07:05
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more